Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

Saved in:
Bibliographic Details
Title: Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Authors: Keystone EC; Mt. Sinai Hospital, Toronto, Ontario, Canada. edkeystone@mtsinai.on.ca, Schiff MH, Kremer JM, Kafka S, Lovy M, DeVries T, Burge DJ
Source: Arthritis and rheumatism [Arthritis Rheum] 2004 Feb; Vol. 50 (2), pp. 353-63.
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 0370605 Publication Model: Print Cited Medium: Print ISSN: 0004-3591 (Print) Linking ISSN: 00043591 NLM ISO Abbreviation: Arthritis Rheum Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0004-3591
DOI:10.1002/art.20019